Pathology and AI: Page 2

DiamiR Biosciences partners with JADBio on diagnostic tests, validation for biomarker panels

Under the deal, DiamiR will apply the capabilities of JADBio’s Automated Machine Learning (AutoML) bioinformatics platform and services to its own microRNA platform.

July 12, 2023

New scanning method creates whole-body “atlases” of biological systems

wildDISCO can create whole-body “atlases” focusing on the nervous system, lymphatic vessels, blood vessels, and immune cells to highlight normal structures and tumors in early stages of formation.

July 13, 2023

CellChorus awarded two grants to accelerate single-cell analysis platform

The grants will be used to accelerate the development of CellChorus’ Time-lapse Imaging Microscopy in Nanowell Grids (TIMING) platform for single-cell analysis.

June 30, 2023

Harvard Medical School, RareCyte developing multiplex imaging for clinical pathology

Multiplex imaging technology enables the integration of microscopic analysis with the visualization of molecular markers in individual cells.

June 26, 2023

Report shows Medicare risked up to $888M in improper payments for molecular pathology test

The HHS Office of Inspector General analyzed Medicare Part B claims associated with payments for more than 450,000 genetic tests billed under Current Procedural Terminology (CPT) code 81408.

June 23, 2023

Proscia, Mindpeak collaborate on AI-enabled pathology workflows

The collaboration will bring together Mindpeak’s algorithms for immunohistochemistry (IHC) quantification and Proscia’s Concentriq Dx software platform

June 20, 2023

Paige launches AI-based product suite for breast cancer diagnosis

The Paige Breast Suite comprises a group of AI tools designed to support each step of breast cancer diagnosis and streamline pathologists’ day-to-day workflows.

June 15, 2023

Proscia survey evaluates adoption of digital pathology among pharmas, CROs

More than half of the survey participants still center their operations around legacy software systems, primarily for basic image viewing.

June 13, 2023

'AI doctor' predicts hospital readmission, health outcomes

New AI program reads doctors' notes to predict health outcomes, including patients' risk of death, hospital stay length, and likelihood of readmission.

June 7, 2023

Nucleai, Mayo Clinic partner on digital pathology

The collaboration combines Nucleai’s AI-enabled spatial biology technology with Mayo’s longitudinally annotated, multimodal data sets, lab services, and clinical diagnostic footprint.

June 5, 2023

Nucleai, Adlai Nortye collaborate on biomarkers for clinical trials

The partnership will combine Nucleai's expertise in extracting and analyzing the quantitative spatial features of pathology images and Adlai Nortye's expertise in drug development and immunotherapy.

May 31, 2023

Lunit, Japan national cancer center collaborate on AI-based pathology for oncology

In collaborative studies with the national cancer center, researchers are evaluating the potential of the Lunit Scope artificial intelligence biomarker platform to predict clinical outcomes for rectal cancer.

May 30, 2023

Previous Page

Page 2 of 173

Next Page